• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定SLC35A1作为多血清型重组腺相关病毒(AAV)载体转导的必需宿主因子。

Identification of SLC35A1 as an essential host factor for the transduction of multi-serotype recombinant adeno-associated virus (AAV) vectors.

作者信息

Zhang Xiujuan, Hao Siyuan, Feng Zehua, Ning Kang, Kuz Cagla Aksu, McFarlin Shane, Richart Donovan, Cheng Fang, Zhang-Chen Ander, McFarlane Richenda, Yan Ziying, Qiu Jianming

机构信息

Department of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, KS 66160, USA.

Department of Anatomy and Cell Biology, University of Iowa, Iowa City, IA 52242, USA.

出版信息

bioRxiv. 2024 Oct 17:2024.10.16.618764. doi: 10.1101/2024.10.16.618764.

DOI:10.1101/2024.10.16.618764
PMID:39463973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11507909/
Abstract

We conducted a genome-wide CRISPR/Cas9 screen in suspension 293-F cells transduced with rAAV5. The highly selected genes revealed after two rounds of screens included the previously reported , , and , along with a cluster of genes involved in glycan biogenesis, Golgi apparatus localization and endoplasmic reticulum penetration. In this report, we focused on solute carrier family 35 member A1 (), a Golgi apparatus-localized cytidine 5'-monophosphate-sialic acid (CMP-SIA) transporter. We confirmed that knockout (KO) significantly decreased rAAV5 transduction to a level lower than that observed in or KO cells. Although KO drastically reduced the expression of α2,6-linked SIA on the cell surface, the expression of α2,3-linked SIA, as well as the cell binding and internalization of rAAV5, were only moderately affected. Moreover, KO significantly diminished the transduction of AAV multi-serotypes, including rAAV2 and rAAV3 which do not utilize SIAs for primary attachment. Notably, the SLC35A1 KO markedly increased transduction of rAAV9 and rAAV11, which primarily attach to cells via binding to galactose. Further analyses revealed that KO significantly decreased vector nuclear import. More importantly, although the C-terminal cytoplasmic tail deletion (ΔC Tail) mutant of SLC35A1 did not drastically decrease SIA expression, it significantly decreased rAAV transduction, as well as vector nuclear import, suggesting the C-tail is critical in these processes. Furthermore, the T128A mutant significantly decreased SIA expression, but still supported rAAV transduction and nuclear import. These findings highlight the involvement of the CMP-SIA transporter in the intracellular trafficking of rAAV vectors post-internalization.

摘要

我们在用rAAV5转导的悬浮293-F细胞中进行了全基因组CRISPR/Cas9筛选。两轮筛选后高度富集的基因包括先前报道的基因,以及一组参与聚糖生物合成、高尔基体定位和内质网穿透的基因。在本报告中,我们重点研究了溶质载体家族35成员A1(SLC35A1),一种定位于高尔基体的胞苷5'-单磷酸-唾液酸(CMP-Sia)转运蛋白。我们证实,SLC35A1基因敲除(KO)显著降低了rAAV5转导,降至低于在其他基因敲除细胞中观察到的水平。虽然SLC35A1基因敲除大幅降低了细胞表面α2,6连接的Sia的表达,但α2,3连接的Sia的表达以及rAAV5的细胞结合和内化仅受到中度影响。此外,SLC35A1基因敲除显著降低了包括rAAV2和rAAV3在内的多种AAV血清型的转导,rAAV2和rAAV3并不利用Sia进行初始附着。值得注意的是,SLC35A1基因敲除显著增加了rAAV9和rAAV11的转导,rAAV9和rAAV11主要通过与半乳糖结合附着于细胞。进一步分析表明,SLC35A1基因敲除显著降低了载体的核输入。更重要的是,虽然SLC35A1的C末端胞质尾缺失(ΔC尾)突变体并未大幅降低Sia表达,但它显著降低了rAAV转导以及载体核输入,表明C尾在这些过程中至关重要。此外,T128A突变体显著降低了Sia表达,但仍支持rAAV转导和核输入。这些发现突出了CMP-Sia转运蛋白在rAAV载体内化后细胞内运输中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9eb/11507909/dd07f779726e/nihpp-2024.10.16.618764v1-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9eb/11507909/89094d522675/nihpp-2024.10.16.618764v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9eb/11507909/c4c2c00fd74e/nihpp-2024.10.16.618764v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9eb/11507909/390dde629cc8/nihpp-2024.10.16.618764v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9eb/11507909/2c5419d5264d/nihpp-2024.10.16.618764v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9eb/11507909/604ec6bbcedd/nihpp-2024.10.16.618764v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9eb/11507909/94055056d518/nihpp-2024.10.16.618764v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9eb/11507909/5c9d9f544c94/nihpp-2024.10.16.618764v1-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9eb/11507909/5fb83fce770b/nihpp-2024.10.16.618764v1-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9eb/11507909/dd07f779726e/nihpp-2024.10.16.618764v1-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9eb/11507909/89094d522675/nihpp-2024.10.16.618764v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9eb/11507909/c4c2c00fd74e/nihpp-2024.10.16.618764v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9eb/11507909/390dde629cc8/nihpp-2024.10.16.618764v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9eb/11507909/2c5419d5264d/nihpp-2024.10.16.618764v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9eb/11507909/604ec6bbcedd/nihpp-2024.10.16.618764v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9eb/11507909/94055056d518/nihpp-2024.10.16.618764v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9eb/11507909/5c9d9f544c94/nihpp-2024.10.16.618764v1-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9eb/11507909/5fb83fce770b/nihpp-2024.10.16.618764v1-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9eb/11507909/dd07f779726e/nihpp-2024.10.16.618764v1-f0009.jpg

相似文献

1
Identification of SLC35A1 as an essential host factor for the transduction of multi-serotype recombinant adeno-associated virus (AAV) vectors.鉴定SLC35A1作为多血清型重组腺相关病毒(AAV)载体转导的必需宿主因子。
bioRxiv. 2024 Oct 17:2024.10.16.618764. doi: 10.1101/2024.10.16.618764.
2
Identification of SLC35A1 as an essential host factor for the transduction of multi-serotype recombinant adeno-associated virus (AAV) vectors.鉴定SLC35A1作为多血清型重组腺相关病毒(AAV)载体转导的必需宿主因子。
mBio. 2025 Jan 8;16(1):e0326824. doi: 10.1128/mbio.03268-24. Epub 2024 Nov 27.
3
Identification of Host Restriction Factors Critical for Recombinant AAV Transduction of Polarized Human Airway Epithelium.鉴定对极化人呼吸道上皮细胞的重组腺相关病毒转导至关重要的宿主限制因子。
bioRxiv. 2023 Sep 27:2023.09.27.559795. doi: 10.1101/2023.09.27.559795.
4
Cytidine Monophosphate -Acetylneuraminic Acid Synthetase and Solute Carrier Family 35 Member A1 Are Required for Reovirus Binding and Infection.胞苷一磷酸-乙酰神经氨酸合酶和溶质载体家族 35 成员 A1 是呼肠孤病毒结合和感染所必需的。
J Virol. 2020 Dec 22;95(2). doi: 10.1128/JVI.01571-20.
5
An interaction between SLC35A1 and ST3Gal4 is differentially affected by CDG-causing mutations in the SLC35A1 gene.SLC35A1 基因中的 CDG 致病突变可使 SLC35A1 与 ST3Gal4 之间的相互作用产生差异。
Biochem Biophys Res Commun. 2022 Dec 20;635:46-51. doi: 10.1016/j.bbrc.2022.10.019. Epub 2022 Oct 11.
6
Genome-Wide CRISPR/Cas9 Screen Reveals a Role for SLC35A1 in the Adsorption of Porcine Deltacoronavirus.全基因组 CRISPR/Cas9 筛选揭示 SLC35A1 在猪德尔塔冠状病毒吸附中的作用。
J Virol. 2022 Dec 21;96(24):e0162622. doi: 10.1128/jvi.01626-22. Epub 2022 Dec 1.
7
Recombinant adeno-associated virus utilizes host cell nuclear import machinery to enter the nucleus.重组腺相关病毒利用宿主细胞核输入机制进入细胞核。
J Virol. 2014 Apr;88(8):4132-44. doi: 10.1128/JVI.02660-13. Epub 2014 Jan 29.
8
The promiscuous binding pocket of SLC35A1 ensures redundant transport of CDP-ribitol to the Golgi.SLC35A1 的混杂结合口袋确保了 CDP-赤藓醇向高尔基体的冗余转运。
J Biol Chem. 2021 Jan-Jun;296:100789. doi: 10.1016/j.jbc.2021.100789. Epub 2021 May 18.
9
The Golgi Calcium ATPase Pump Plays an Essential Role in Adeno-associated Virus Trafficking and Transduction.高尔基钙 ATP 酶泵在腺相关病毒的运输和转导中起着至关重要的作用。
J Virol. 2020 Oct 14;94(21). doi: 10.1128/JVI.01604-20.
10
Knockout of the CMP-Sialic Acid Transporter SLC35A1 in Human Cell Lines Increases Transduction Efficiency of Adeno-Associated Virus 9: Implications for Gene Therapy Potency Assays.敲除人源 CMP-唾液酸转运蛋白 SLC35A1 可提高腺相关病毒 9 的转导效率:对基因治疗效力检测的启示。
Cells. 2021 May 19;10(5):1259. doi: 10.3390/cells10051259.

本文引用的文献

1
Cell binding, uptake, and infection of influenza A virus using recombinant antibody-based receptors.使用基于重组抗体的受体对甲型流感病毒进行细胞结合、摄取和感染。
J Virol. 2025 May 20;99(5):e0227524. doi: 10.1128/jvi.02275-24. Epub 2025 Apr 10.
2
Inhalation of SP-101 Followed by Inhaled Doxorubicin Results in Robust and Durable Transgene Expression in the Airways of Wild-Type and Cystic Fibrosis Ferrets.吸入 SP-101 后再吸入多柔比星可在野生型和囊性纤维化雪貂的气道中产生强大且持久的转基因表达。
Hum Gene Ther. 2024 Sep;35(17-18):710-725. doi: 10.1089/hum.2024.064. Epub 2024 Sep 4.
3
SP-101, A Novel Adeno-Associated Virus Gene Therapy for the Treatment of Cystic Fibrosis, Mediates Functional Correction of Primary Human Airway Epithelia From Donors with Cystic Fibrosis.
SP-101,一种新型腺相关病毒基因疗法,用于治疗囊性纤维化,介导来自囊性纤维化供体的原代人气道上皮的功能矫正。
Hum Gene Ther. 2024 Sep;35(17-18):695-709. doi: 10.1089/hum.2024.063. Epub 2024 Aug 29.
4
Adeno-associated virus as a delivery vector for gene therapy of human diseases.腺相关病毒作为人类疾病基因治疗的递送载体。
Signal Transduct Target Ther. 2024 Apr 3;9(1):78. doi: 10.1038/s41392-024-01780-w.
5
Identification of host essential factors for recombinant AAV transduction of the polarized human airway epithelium.鉴定重组腺相关病毒转导极化人呼吸道上皮细胞的宿主必需因子。
J Virol. 2023 Dec 21;97(12):e0133023. doi: 10.1128/jvi.01330-23. Epub 2023 Nov 15.
6
BioMarin's ROCTAVIAN Wins Food and Drug Administration Approval As First Gene Therapy for Severe Hemophilia A.BioMarin公司的ROCTAVIAN获得美国食品药品监督管理局批准,成为首个用于重度A型血友病的基因疗法。
Hum Gene Ther. 2023 Aug;34(15-16):665-668. doi: 10.1089/hum.2023.29251.bfs.
7
Delandistrogene Moxeparvovec: First Approval.Delandistrogene Moxeparvovec:首次获批
Drugs. 2023 Sep;83(14):1323-1329. doi: 10.1007/s40265-023-01929-x.
8
Various AAV Serotypes and Their Applications in Gene Therapy: An Overview.各种 AAV 血清型及其在基因治疗中的应用:概述。
Cells. 2023 Mar 1;12(5):785. doi: 10.3390/cells12050785.
9
[A long-awaited - but prohibitively expensive - therapy].一种期待已久但价格高得令人望而却步的疗法。
Med Sci (Paris). 2023 Feb;39(2):187-190. doi: 10.1051/medsci/2023003. Epub 2023 Feb 17.
10
Adeno-Associated Virus Monoinfection Induces a DNA Damage Response and DNA Repair That Contributes to Viral DNA Replication.腺相关病毒单感染诱导 DNA 损伤反应和修复,有助于病毒 DNA 复制。
mBio. 2023 Feb 28;14(1):e0352822. doi: 10.1128/mbio.03528-22. Epub 2023 Jan 31.